PERISEPT

Serial Number 97886769
731

Registration Progress

Application Filed
Apr 13, 2023
Under Examination
Jul 23, 2024
Approved for Publication
May 28, 2024
Published for Opposition
May 28, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Jan 23, 2026 190 days

Trademark Image

PERISEPT

Basic Information

Serial Number
97886769
Filing Date
April 13, 2023
Published for Opposition
May 28, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Jul 8, 2025
Application
Pending
Classes
005

Rights Holder

Stiehl Tech LLC

16
Address
111 East Main Street
Salem, IL 62881

Ownership History

Stiehl Tech LLC

Original Applicant
16
Salem, IL

Stiehl Tech LLC

Owner at Publication
16
Salem, IL

Legal Representation

Attorney
Mark J. Diliberti

USPTO Deadlines

Next Deadline
190 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
January 23, 2026
Extension Available
Until July 23, 2025

Application History

32 events
Date Code Type Description Documents
Jul 9, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 8, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 8, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 8, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 4, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 14, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 14, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 13, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 23, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 28, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 28, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 8, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 23, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 15, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 15, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 15, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 15, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 26, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Mar 26, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 26, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 7, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Feb 7, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Feb 7, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 2, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 1, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 1, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 10, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 10, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 10, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 9, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 8, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 17, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Therapeutic pharmaceutical for the treatment of wounds; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations for wounds; hydrogel for medical purposes; syringes sold filled with hydrogel for medical purposes; syringes sold filled with temperature sensitive hydrogel for medical purposes; therapeutic agents for use in the treatment of wounds; syringes sold filled with therapeutic agents for use in the treatment of wounds; therapeutic pharmaceuticals for use in the treatment of wounds; syringes sold filled with therapeutic pharmaceuticals for use in the treatment of wounds; therapeutic agents featuring antimicrobial preservatives for use in the treatment of wounds; syringes sold filled with therapeutic agents featuring antimicrobial preservatives for use in the treatment of wounds; pharmaceutical preparations, namely, a drug delivery system comprised of topical antiseptics that may be added to appropriate gels and polymer delivery system for the continuous release of a wide variety of therapeutic agents; syringes sold filled with pharmaceutical preparations and substances for the treatment of damaged skin and tissue; antibiotics; mixed antibiotic preparations for use in the treatment of general and local bacteria; syringes sold filled with antibiotics; antiseptics; antiseptic preparations for use in the treatment of general and local bacteria; syringes sold filled with antiseptics; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of wounds

Classification

International Classes
005